Liver X receptor
FunctionLiver X receptors (LXR) are ligand-activated transcription factors of the nuclear receptor family. There are two LXR isoforms α and β which form heterodimers with retinoic X receptor upon activation and bind to the LXR response element found in the promoter region of the target genes[1]. LXR is a lipogenic transcription factor[2]. LXRs modulate the expression of genes in cholesterol and lipid metabolism in response to changes in cellular cholesterol status.
See also Intracellular receptors DiseaseTreatment of mice demonstrating Wilson disease with LXR agonist reduced disease manifestations without worsening neurological symptoms associated with the conventional therapy based on copper chelation[4]. RelevanceLXRs have emerged as promising drug targets for anti-atherosclerotic therapies[5]. Structural highlightsHuman liver X receptor β ligand binding domain complex with retinoic X receptor β and modulator. LXR modulator binds to the LXR in the LXR/retinoic X receptor β heterodimer in a hydrophobic pocket[6].
| ||||||||||||
3D Structures of liver X receptor
Updated on 10-July-2024
- Liver X receptor α
- Liver X receptor β
- 1upv, 1upw, 5jy3, 3kfc, 4rak, 6s4n, 6s4t, 6s4u, 6s5k – hLXR LBD + agonist
- 6k9g, 6k9h, 6k9m – hLXR LBD (mutant) + agonist
- 1pq6, 1pqc, 1pq9 – hLXR LBD + ligand
- 6jio – hLXR LBD (mutant) + ligand
- 5i4v – hLXR LBD + retinoic X receptor β + agonist
- 5kyj, 5kya – hLXR LBD + retinoic X receptor β + modulator
- 3fal – hLXR LBD + retinoic X receptor β + modulator + retinoic acid
- 5hjp – hLXR LBD + retinoic X receptor β + agonist
- 4nqa – hLXR LBD + retinoic X receptor β + NCOA-2 peptide + DNA
- 4dk7, 4dk8, 5avi – hLXR LBD + NCOA-1 peptide + agonist
- 1p8d – hLXR LBD + NCOA-1 peptide + cholesterol derivative
- 3l0e – hLXR LBD + NCOA-2 peptide + inhibitor
- 1upv, 1upw, 5jy3, 3kfc, 4rak, 6s4n, 6s4t, 6s4u, 6s5k – hLXR LBD + agonist
References
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, Alexander Berchansky, Jaime Prilusky, Joel L. Sussman